PX1 Research provides analytical-grade Chonluten tripeptide engineered specifically for laboratory research into monocyte activity regulation and cell signaling. Every lot undergoes rigorous HPLC and mass spectrometry validation to deliver uncompromised purity, lot-to-lot consistency, and documented low endotoxin levels for critical in vitro and preclinical assays.
PX1 Research provides analytical-grade Chonluten tripeptide engineered specifically for laboratory research into monocyte activity regulation and cell signaling. Every lot undergoes rigorous HPLC and mass spectrometry validation to deliver uncompromised purity, lot-to-lot consistency, and documented low endotoxin levels for critical in vitro and preclinical assays.
When evaluating a supplier to buy monocyte activity regulation Chonluten for preclinical investigation, research laboratories require certified analytical purity, comprehensive lot documentation, and low endotoxin thresholds. PX1 Research supplies high-purity, USA-manufactured Chonluten paired with full third-party Certificate of Analysis (COA) verification by HPLC and ESI-MS for rigorous laboratory protocols.
Monocytes and macrophage lineages represent vital components of the innate immune response, mediating tissue remodeling, inflammatory cytokine cascades, and cellular repair mechanism assays. Investigators examining peptide-driven modulation of gene expression rely on standardized synthetic constructs to eliminate experimental variability caused by impurities or variable peptide salt concentrations.
Chonluten is a synthetic tripeptide consisting of L-glutamic acid, L-aspartic acid, and L-arginine (H-Glu-Asp-Arg-OH, sequence EDG). Classified within the broader category of short-chain bioregulators, this low-molecular-weight sequence was developed to mimic endogenous regulatory oligopeptides that interact directly with chromatin structure.
Due to its minimal molecular mass (approximately 389.36 g/mol), Chonluten exhibits exceptional solubility in aqueous buffer systems and precise cell-permeable dynamics in cell culture models. Investigators exploring structural biochemistry utilize all peptides synthesized under controlled GMP-compliant parameters to verify sequence specificity without cross-contamination from adjacent peptide fragments.
Preclinical studies suggest that short tripeptides like Chonluten regulate monocyte activity primarily through sequence-specific interactions with the double helix of DNA. In vitro binding assays demonstrate that EDG tripeptides bind into the major and minor grooves of specific gene promoter regions, altering nucleosome positioning and modulating transcription factor accessibility.
In monocyte culture models, this nuclear interaction influences the expression rates of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). By dampening excessive nuclear factor kappa B (NF-κB) activation, Chonluten displays a capacity to modulate hyper-reactive monocyte responses toward a homeostasis-promoting transcriptional state in primary cellular assays.
Furthermore, in vitro findings indicate that Chonluten helps regulate the generation of reactive oxygen species (ROS) within monocyte-derived macrophages. Through upregulation of endogenous antioxidant enzyme pathways—including superoxide dismutase (SOD) and glutathione peroxidase (GPx)—the peptide assists in stabilizing mitochondrial membrane potential under oxidative stress conditions.
In published rodent models of acute lung injury and endotoxin-induced inflammation, administration of Chonluten demonstrated marked attenuation of neutrophil and monocyte infiltration into bronchoalveolar lavage fluid. Investigators observed that peptide exposure correlated with normalized surfactant protein expression and preserved alveolar epithelial structural integrity.
Additional research literature highlights the peptide's role in bronchial epithelial-monocyte co-cultures. When primary human monocytes are co-cultured with airway epithelial cells under lipopolysaccharide (LPS) challenge, Chonluten downregulates adhesion molecule expression—such as ICAM-1 and VCAM-1—thereby reducing monocyte transendothelial migration rates in experimental setups.
Data compiled from animal models of chronic bronchial inflammation also suggest that EDG tripeptide administration modulates macrophage polarization, shifting phenotypic markers from the pro-inflammatory M1 phenotype toward the pro-resolution M2 phenotype. Researchers access our comprehensive research hub to review mechanistic literature regarding peptide-driven cellular signaling.
To properly contextualize Chonluten within comparative immunology and cell signaling assays, investigators frequently evaluate its activity alongside other targeted oligopeptides. While Chonluten (EDG) demonstrates specific affinity for pulmonary and monocyte gene regulation, compounds such as Epithalon focus primarily on telomerase induction and neuroendocrine modulation, and Thymalin targets broader T-cell differentiation pathways. Additionally, research into Bronchogen respiratory research highlights overlapping tissue specificity in airway models, whereas general Khavinson peptides demonstrate distinct tissue-tropic effects depending on their amino acid sequence.
The table below highlights key biochemical distinctions among these short-chain research bioregulators:
• Chonluten (EDG): Primary target includes monocyte activity, macrophage polarization, and bronchial tissue gene transcription. • Bronchogen (KED): Target focus centered on lung epithelial cell proliferation and structural remodeling markers. • Thymalin: Complex peptide fraction evaluated for thymocyte maturation and systemic immune system recalibration. • Epithalon (AEDG): Quadripeptide researched for pineal gland regulation, telomerase activation, and circadian rhythm alignment.
When selecting a supplier for research-grade Chonluten, laboratory managers must demand rigorous verification of purity and chemical identity. Substandard peptide synthesis can introduce truncated sequences, residual protecting groups, and trifluoroacetate (TFA) salt imbalances that skew in vitro cell culture viability assays.
PX1 Research enforces strict quality control parameters for every production lot. Every shipment is accompanied by independently verified analytical reports:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Ensures purity levels exceeding 98.0%, displaying sharp single-peak retention without underlying synthesis degradation peaks. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular mass matching the theoretical weight of H-Glu-Asp-Arg-OH (389.36 Da). 3. Amino Acid Analysis (AAA): Confirms precise stoichiometric ratios of glutamate, aspartate, and arginine across the lyophilized matrix.
For researchers conducting monocyte activity assays, endotoxin contamination represents a significant confounding variable. Bacterial lipopolysaccharides (LPS) directly activate monocyte Toll-like receptor 4 (TLR4) complexes, masking the potential regulatory effects of the peptide under study.
To prevent experimental artifact, PX1 Research subjects all peptide lots to quantitative Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing. Our research-grade Chonluten is batch-certified to contain sub-threshold endotoxin levels (<0.01 EU/mg), ensuring that monocyte activation observed in downstream assays is attributable strictly to experimental parameters rather than bacterial pyrogen contamination.
Proper reconstitution technique is critical to maintain sequence integrity and prevent aggregation or peptide loss during handling. Chonluten is supplied as a sterile, lyophilized white powder packaged under inert gas to maintain stability.
Laboratory standard operating procedures for reconstitution generally follow these guidelines:
• Solubilization: Reconstitute the lyophilized powder using sterile, nuclease-free research-grade water or sterile phosphate-buffered saline (PBS, pH 7.4). Avoid high-shear vortexing; gentle inversion or micro-pipetting is recommended. • Concentration: Prepare primary stock solutions at concentrations ranging from 1.0 mg/mL to 10.0 mg/mL based on assay microplate requirements. • Aliquoting: To minimize freeze-thaw degradation, aliquot primary stocks into single-use polypropylene low-binding microcentrifuge tubes prior to storage.
Lyophilized Chonluten exhibits strong structural stability when stored under controlled environment conditions. Desiccated vials should be preserved at -20°C for medium-term storage or -80°C for long-term preservation to protect against ambient atmospheric moisture uptake.
Following reconstitution, liquid stock solutions should be kept at 4°C for immediate short-term use (not exceeding 48 to 72 hours). Reconstituted aliquots intended for extended experimental series must be frozen immediately at -80°C. Repeated freeze-thaw cycles must be avoided to prevent peptide backbone cleavage and loss of target binding affinity.
PX1 Research serves as a premier USA supplier of specialized analytical peptides, dedicated exclusively to supporting academic institutions, biotechnology organizations, and government research facilities. We maintain state-of-the-art storage and distribution centers in California and Arizona to guarantee rapid, temperature-monitored transit.
Orders placed Monday through Friday before 12:00 PM PST ship same-day via expedited courier services. Institutional purchasers requiring bulk quantities, custom packaging sizes, or recurring lot-reserved supply can access specialized procurement channels through our wholesale laboratory account portal.
Where can laboratories buy Chonluten for monocyte activity research?
Qualified research laboratories can purchase high-purity Chonluten directly from PX1 Research. Every lot is manufactured under strict quality standards in the USA and supplied with independent HPLC, MS, and endotoxin COAs.
What is the primary target of Chonluten in cell culture models?
In vitro research indicates Chonluten (EDG) interacts directly with nuclear DNA promoter sequences, modulating the expression of inflammatory cytokines and ROS production pathways in monocyte and macrophage cell lines.
What purity levels are guaranteed for PX1 Research Chonluten?
PX1 Research guarantees a minimum chemical purity of 98.0% as measured by RP-HPLC, with sequence identity confirmed via ESI-MS mass spectrometry for every single production lot.
Why is endotoxin testing vital for monocyte activity regulation research?
Monocytes are exquisitely sensitive to bacterial endotoxins (LPS). Low-endotoxin certification (<0.01 EU/mg) ensures that cellular activation responses in experiments are driven by the research peptide rather than pyrogenic contaminants.
How should lyophilized Chonluten be stored upon delivery?
Desiccated lyophilized vials should be stored at -20°C or -80°C upon receipt. Protect the product from light and atmospheric moisture exposure until reconstitution.
What solvent is recommended for reconstituting Chonluten?
Chonluten is readily soluble in sterile, nuclease-free water or sterile PBS (pH 7.4). Gentle inversion is suggested to achieve complete dissolution without shearing.
Is PX1 Research Chonluten approved for clinical or human use?
No. All products offered by PX1 Research are strictly for laboratory research, in vitro investigation, and preclinical analytical testing. They are explicitly not for human or veterinary use.
Does PX1 Research provide bulk supply options for university facilities?
Yes, PX1 Research supports institutional procurement with custom lot sizing, reserved lot numbers, and dedicated volume pricing through our wholesale lab program.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.